BRMS1L-induced FZD10 epigenetic silencing through HDAC1 recruitment and histone H3K9 deacetylation at the promoter can suppress breast cancer metastasis by inhibiting aberrant activation of WNT3-FZD10-β-catenin signaling [34]. Here, BRMS1L is linked to breast cancer.